ETFs Jointown Pharmaceutical Group Co., Ltd

600998

CNE100000W45

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2025-06-13			5-day change	1st Jan Change
5.440 ^CNY	-0.18%		+1.68%	+6.25%

Jun. 06	Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection	MT
May. 19	Jointown to Invest 23 Million Yuan Into Pharma-Focused Investment Fund	MT

ETFs positioned on Jointown Pharmaceutical Group Co., Ltd

Name	Weight	AuM	1st Jan change
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD	0.42%	0 M€	-19.71%	-
GOLDMAN SACHS ACTIVEBETA EMERGING MARKETS EQUITY UCITS ETF - ACC - USD	0.06%	8 M€	+14.08%	-
LEADERSHARES EQUITY SKEW ETF - USD	0%	89 M€	-4.70%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	0%	33,076 M€	+10.80%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0%	32 M€	+12.86%	-
NOMURA NEXT FUNDS EMERGING MARKET EQUITY MSCI-EM (UNHEDGED) ETF - JPY	0%	17 M€	+0.20%	-

Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.

Employees

30,169

Sector

Pharmaceuticals

Calendar

Sep. 01 - Q2 2025 Earnings Release (Projected)

More about the company